Gene structure and expression of the 5′-(CGG)n-3′- binding protein (CGGBP1)

Genomics

Volumn 83, Issue 1, 2004, Pages 106-118

  Naumann, Frauke ^a   Remus, Ralph ^a   Schmitz, Birgit ^a   Doerfler, Walter ^a  

^a UNIVERSITY OF COLOGNE   (Germany)

Author keywords

Gene regulation; Methylation; Promoter; Trinucleotide repeats

Indexed keywords

5' (CGG) N 3' BINDING PROTEIN; BINDING PROTEIN; MESSENGER RNA; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CHROMOSOME 3P; DNA METHYLATION; EMBRYO; EMBRYONAL TISSUE; FETUS; GENE INACTIVATION; GENE MAPPING; GENE STRUCTURE; GENETIC CONSERVATION; GENETIC TRANSCRIPTION; GENETIC TRANSFECTION; GENOME ANALYSIS; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; POLYADENYLATION; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN BINDING; UNTRANSLATED REGION;

MURINAE;

EID: 0344688176     PISSN: 08887543     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0888-7543(03)00212-X     Document Type: Article

References (49)

1. Richards R.I., Sutherland G.R. Dynamic mutations: a new class of mutations causing human disease. Cell. 70:1992;709-712.
2. Margolis R.L., McInnis M.G., Rosenblatt A., Ross C.A. Trinucleotide repeat expansion and neuropsychiatric disease. Arch. Gen. Psychiatry. 56:1999;1019-1031.
3. Cummings C.J., Zoghbi H.Y. Fourteen and counting: unraveling trinucleotide repeat diseases. Hum. Mol. Genet. 9:2000;909-916.
4. Margolis R.L., Ross C.A. Expansion explosion: new clues to the pathogenesis of repeat expansion neurodegenerative diseases. Trends Mol. Med. 7:2001;479-482.
5. Ranum L.P., Day J.W. Dominantly inherited, non-coding microsatellite expansion disorders. Curr. Opin. Genet. Dev. 12:2002;266-271.
6. Sherman S. Epidemiology. Hagerman R.J., Hagerman P.J. Fragile X Syndrome: Diagnosis, Treatment and Research. 2002;136-168 Johns Hopkins Univ. Press, Baltimore.
7. Jin P., Warren S.T. Understanding the molecular basis of fragile X syndrome. Hum. Mol. Genet. 9:2000;901-908.
8. O'Donnell W.T., Warren S.T. A decade of molecular studies of fragile X syndrome. Annu. Rev. Neurosci. 25:2002;315-338.
9. Bardoni B., Mandel J.-L. Advances in understanding of fragile X pathogenesis and FMRP function, and in identification of X linked mental retardation genes. Curr. Opin. Genet. Dev. 12:2002;284-293.
10. Maddalena A.et al. Technical standards and guidelines for fragile X: the first of a series of disease-specific supplements to the standards and guidelines for clinical genetics laboratories of the American College of Medical Genetics. Genet. Med. 3:2001;200-205.
11. Verkerk A.J.M.H.et al. Identification of a gene (FMR-1) containing a CGG repeat coincident with a breakpoint cluster region exhibiting length variation in fragile X syndrome. Cell. 65:1991;905-914.
12. Fu Y.H.et al. Variation of the CGG repeat at the fragile X site results in genetic instability: resolution of the Sherman paradox. Cell. 67:1991;1047-1058.
13. Oberlé I.et al. Instability of a 550 base pair DNA segment and abnormal methylation in fragile X chromosome. Science. 252:1991;1097-1102.
14. Sutcliffe J.S.et al. DNA methylation represses FMR-1 transcription in fragile X syndrome. Hum. Mol. Genet. 1:1992;397-400.
15. Hagerman R.J. The physical and behavioral phenotype. Hagerman R.J., Hagerman P.J. Fragile X Syndrome: Diagnosis, Treatment and Research. 2002;3-109 Johns Hopkins Univ. Press, Baltimore.
16. Tassone F., Hagerman R.J., Taylor A.K., Gane L.W., Godfrey T.E., Hagerman P.J. Elevated levels of FMR1 mRNA in carrier males: A new mechanism of involvement in the fragile X syndrome. Am. J. Hum. Genet. 66:2000;6-15.
17. Kenneson A., Zhang F., Hagedorn C.H., Warren S.T. Reduced FMRP and increased FMR1 transcription is proportionally associated with CGG repeat number in intermediate-length and premutation carriers. Hum. Mol. Genet. 10:2001;1449-1454.
18. Hagerman R.J., Hagerman P.J. The fragile X premutation: into the phenotypic fold. Curr. Opin. Genet. Dev. 12:2002;278-283.
19. Brown T.W. The molecular biology of the fragile X mutation. Hagerman R.J., Hagerman P.J. Fragile X Syndrome: Diagnosis, Treatment and Research. 2002;110-135 Johns Hopkins Univ. Press, Baltimore.
20. Wells R.D., Warren S.T. Genetic Instabilities and Hereditary Neurological Disorders. 1998;Academic Press, San Diego.
21. Cleary J.D., Nichol K., Wang Y.-H., Pearson C.E. Evidence of cis-acting factors in replication-mediated trinucleotide repeat instability in primate cells. Nat. Genet. 31:2002;37-46.
22. Sinden R.R., Potamen V.N., Oussatcheva E.A., Pearson C.E., Lyubchenko Y.L., Shlyakhtenko L.S. Triplet repeat DNA structures and human genetic disease: dynamic mutations from dynamic DNA. J. Biosci. 27:2002;53-65.
23. Behn-Krappa A., Doerfler W. Enzymatic amplification of synthetic oligodeoxyribonucleotides: implications for triplet repeat expansions in the human genome. Hum. Mutat. 3:1994;19-24.
24. McMurray C.T. DNA secondary structure: A common and causative factor for expansion in human disease. Proc. Natl. Acad. Sci. USA. 96:1999;1823-1825.
25. n in the human FMR1 gene. J. Biol. Chem. 271:1996;4327-4334.
26. Deissler H.et al. Rapid protein sequencing by tandem mass spectrometry and cDNA cloning of p20-CGGBP. J. Biol. Chem. 272:1997;16761-16768.
27. n-3′-binding protein is targeted to the nucleus and affects the activity of the FMR1 promoter. J. Biol. Chem. 275:2000;6447-6452.
28. Boguski M.S., Lowe T.M., Tolstoshev C.M. dbEST - database for "expressed sequence tags" Nat. Genet. 4:1993;332-333.
29. International Human Genome Sequencing Consortium Initial sequencing and analysis of the human genome. Nature. 409:2001;860-921.
30. Altschul S.F.et al. Gapped BLAST and PSI-BLAST: a new generation of protein database search programs. Nucleic Acids Res. 25:1997;3389-3402.
31. Kozak M. An analysis of 5′-noncoding sequences from 699 vertebrate messenger RNAs. Nucleic Acids Res. 15:1987;8125-8148.
32. Sheets M.D., Ogg S.C., Wickens M.P. Point mutations in AAUAAA and the poly (A) addition site: effects on the accuracy and efficiency of cleavage and polyadenylation in vitro. Nucleic Acids Res. 18:1990;5799-5805.
33. Scherf M., Klingenhoff A., Werner T. Highly specific localization of promoter regions in large genomic sequences by PromoterInspector: a novel context analysis approach. J. Mol. Biol. 297:2000;599-606.
34. Solovyev V., Salamov A. The Gene-Finder computer tools for analysis of human and model organisms genome sequences. ISMB. 5:1997;294-302.
35. Frommer M.et al. A genomic sequencing protocol that yields a positive display of 5-methylcytosine residues in individual DNA strands. Proc. Natl. Acad. Sci. USA. 89:1992;1827-1831.
36. n-3′ repeats in the human genome. J. Biol. Chem. 273:1998;30466-30471.
37. Tóth F., Gáspári Z., Jurka J. Microsatellites in different eukaryotic genomes: survey and analysis. Genome Res. 10:2000;967-981.
38. Katti M.V., Ranjekar P.K., Gupta V.S. Differential distribution of simple sequence repeats in eukaryotic genome sequences. Mol. Biol. Evol. 18:2001;1161-1167.
39. Malter H.et al. Characterization of the full fragile X syndrome mutation in fetal gametes. Nat. Genet. 15:1997;165-169.
40. Kozak M. Interpreting cDNA sequences: some insights from studies on translation. Mamm. Genome. 7:1996;563-574.
41. Kochetov A.V.et al. Eukaryotic mRNAs encoding abundant and scarce proteins are statistically dissimilar in many structural features. FEBS Lett. 440:1998;351-355.
42. Meijer H.A., Thomas A.A.M. Control of eukaryotic protein synthesis by upstream open reading frames in the 5′-untranslated region of an mRNA. Biochem. J. 367:2002;1-11.
43. Hinds H.L.et al. Tissue specific expression of FMR-1 provides evidence for a functional role in fragile X syndrome. Nat. Genet. 3:1993;36-43.
44. Willemsen R.et al. The FMR1 CGG repeat mouse displays ubiquitin-positive intranuclear neuronal inclusions; implications for the cerebellar tremor/ataxia syndrome. Hum. Mol. Genet. 12:2003;949-959.
45. Doerfler W. DNA methylation and gene activity. Annu. Rev. Biochem. 52:1983;93-124.
46. Torres R.M., Kühn R. Laboratory Protocols for Conditional Gene Targeting. 1998;Oxford Univ. Press, Oxford.
47. Mouse Genome Sequencing Consortium Initial sequencing and comparative analysis of the mouse genome. Nature. 420:2002;520-562.
48. Lichter P.et al. High-resolution mapping of human chromosome 11 by in situ hybridization with cosmid clones. Science. 247:1990;64-69.
49. Remus R., Kämmer C., Heller H., Schmitz B., Schell G., Doerfler W. Insertion of foreign DNA into an established mammalian genome can alter the methylation of cellular DNA sequences. J. Virol. 73:1999;1010-1022.